美国

我们是谁

  • 4 月 5, 2022
    达拉非尼 + 曲美替尼 + PDR001 在结直肠癌中的应用
  • 4 月 5, 2022
    肿瘤诊断精准免疫肿瘤学和体细胞靶向合理性（TAPISTRY）平台研究
  • 4 月 5, 2022
    eFT226 对部分晚期实体瘤恶性肿瘤受试者的研究
  • 4 月 5, 2022
    Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
  • 4 月 5, 2022
    Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
  • 4 月 5, 2022
    Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
  • 4 月 5, 2022
    A Study of ALX148 With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
  • 4 月 5, 2022
    晚期或转移性实体瘤 NGM831 单药及与 Pembrolizumab 联合用药研究
  • 4 月 5, 2022
    Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
  • 4 月 5, 2022
    Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck